Correlation Between Nexalin Technology and ReShape Lifesciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nexalin Technology and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexalin Technology and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nexalin Technology and ReShape Lifesciences, you can compare the effects of market volatilities on Nexalin Technology and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexalin Technology with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexalin Technology and ReShape Lifesciences.

Diversification Opportunities for Nexalin Technology and ReShape Lifesciences

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Nexalin and ReShape is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Nexalin Technology and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and Nexalin Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexalin Technology are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of Nexalin Technology i.e., Nexalin Technology and ReShape Lifesciences go up and down completely randomly.

Pair Corralation between Nexalin Technology and ReShape Lifesciences

Considering the 90-day investment horizon Nexalin Technology is expected to generate 1.04 times more return on investment than ReShape Lifesciences. However, Nexalin Technology is 1.04 times more volatile than ReShape Lifesciences. It trades about -0.05 of its potential returns per unit of risk. ReShape Lifesciences is currently generating about -0.12 per unit of risk. If you would invest  321.00  in Nexalin Technology on November 3, 2024 and sell it today you would lose (29.00) from holding Nexalin Technology or give up 9.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Nexalin Technology  vs.  ReShape Lifesciences

 Performance 
       Timeline  
Nexalin Technology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.
ReShape Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Nexalin Technology and ReShape Lifesciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nexalin Technology and ReShape Lifesciences

The main advantage of trading using opposite Nexalin Technology and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexalin Technology position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.
The idea behind Nexalin Technology and ReShape Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Technical Analysis
Check basic technical indicators and analysis based on most latest market data